Autoimmunity and Clinical Pathology Amelioration in SLE by Dexamethasone Primed Mesenchymal Stem Cell Derived Conditioned Media
July 2024
Studysummary This study suggests that using cell-free dexamethasone-primed stem cell media may offer a promising alternative treatment for systemic lupus erythematosus, showing immunomodulatory benefits and therapeutic efficacy in reducing various complications.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on biorxiv.org →